Table 4.: Spirometric Values and PAQLQ Scores at the First Visit in the Two Subgroups of Patients with Positive Bronchodilation Test (n=17) who had an Adjustment in their Asthma Therapy (First Group; n= 8), Consisting of the Introduction of or Increase in Inhaled Corticosteroids (ICS), and who had No Adjustment in their Therapy (Second Group; n=9)

  Patients with Adjustment in Therapy (n=8) Patients without Adjustment in Therapy (n=9 All Patients with Positive Bronchodilation Test (n=17) p Value
Mean FVC ± SD 107%±15% 112%±14% 110%± 15% 0.475
Mean FEV1 ± SD 91%±10% 92%±10% 92% ±10% 0.840
Mean FEV1/FVC ± SD 86%±12% 82%±10% 84% ±11% 0.465
Mean Delta FEV1*± SD 19%±6% 16%±6% 17.5%±6% 0.320
Mean PAQLQscore ± SD 6.48±0.79 6.73±0.55 6.43±0.52 0.456

No differences between the two groups are statistically significant* Delta FEV1 = (FEV1 post bronchodilation – FEV1 at vaseline) / FEV1 at baseline; ‡PAQLQ: Pediatric Asthma Quality of Life Questionnaire